This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2023 Apr 20;388(16):1529-1532.

doi: 10.1056/NEJMsb2300232.

Immune Checkpoint Inhibitors - The Need for Innovation

P Connor Johnson¹, Justin F Gainor¹, Ryan J Sullivan¹, Dan L Longo¹, Bruce Chabner¹

Affiliations

Affiliation

¹ From the Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital (P.C.J., J.F.G., R.J.S., B.C.), and Harvard Medical School (P.C.J., J.F.G., R.J.S., B.C.) - both in Boston.

PMID: 37075146
DOI: 10.1056/NEJMsb2300232

Immune Checkpoint Inhibitors - The Need for Innovation

P Connor Johnson et al. N Engl J Med. 2023.

. 2023 Apr 20;388(16):1529-1532.

doi: 10.1056/NEJMsb2300232.

Authors

P Connor Johnson¹, Justin F Gainor¹, Ryan J Sullivan¹, Dan L Longo¹, Bruce Chabner¹

Affiliation

¹ From the Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital (P.C.J., J.F.G., R.J.S., B.C.), and Harvard Medical School (P.C.J., J.F.G., R.J.S., B.C.) - both in Boston.

PMID: 37075146
DOI: 10.1056/NEJMsb2300232

No abstract available

PubMed Disclaimer

References

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.